Safety and efficacy of tofacitinib for treatment of ulcerative colitis: final analysis of OCTAVE Open, an open-label, long-term extension study with up to 7.0  years of treatment

CONCLUSION: Tofacitinib demonstrated consistent safety up to 7.0 years. Data collected up to Month 36 support long-term efficacy beyond the 52-week maintenance study.PMID:34854095 | DOI:10.1111/apt.16712

Source: Herpes - December 2, 2021 Category: Infectious Diseases Authors: William J Sandborn Nervin Lawendy Silvio Danese Chinyu Su Edward V Loftus Ailsa Hart Iris Dotan Ad érson O M C Damião Donna T Judd Xiang Guo Irene Modesto Wenjin Wang Julian Pan és Source Type: research